...
首页> 外文期刊>Radiation Oncology Journal >The Role of Pelvic Irradiation after Hysterectomy in Early Stage Cervical Carcinoma with Pelvic Nodal Metastasis
【24h】

The Role of Pelvic Irradiation after Hysterectomy in Early Stage Cervical Carcinoma with Pelvic Nodal Metastasis

机译:子宫切除术后盆腔照射在早期宫颈癌伴盆腔淋巴结转移中的作用

获取原文

摘要

PURPOSE: To determine the role of pelvic irradiation in stage I or IIA cervical carcinoma with pelvic nodal metastasis after hysterectomy and bilateral pelvic lymphadenectomy. MATERIAL AND METHODS: This is a retrospective study of 68 cervical carcinoma patients who were found to have pelvic nodal metastasis at hysterectomy and received pelvic irradiation from 1983 to 1996 at Inje University Seoul Paik Hospital. External beam radiation therapy to pelvis was delivered using 4 MeV Linac and intracavitary irradiation was given via vaginal ovoids or cylinders. Five-year survival and disease-free survival were estimated by Kaplan-Meier Method and prognostic factors related to survival were analysed by log-rank test and Cox proportional hazards regression model. RESULTS: Median length of follow-up was 52months. Five-year overall survival and disease-free survival (DFS) were 81.8% and 81.7% respectively. Patients with endometrial invasion had a 57.1% 5-year DFS compared to 87.5% for those without endometrial invasion (p=0.0074). Multivariate analysis revealed endometrial invasion as an only statistically significant prognostic factor for 5-year DFS. Among total 15 (22%) recurrences, pelvic recurrences occcured in 4 cases and distant metastases occurred in 13 cases. CONCLUSION: We have been able to confirm previous results demonstrating marked decrease in local recurrence after pelvic irradiation. In view of the high proportion of distant metastasis found in this study, a trial of aggressive adjuvant systemic therapy and irradiation in early stage cervical carcinoma patients with pelvic nodal metastasis, especially with endometrial invasion, appears to be warranted.
机译:目的:确定盆腔放疗在子宫或双侧盆腔淋巴结清扫术后I或IIA期宫颈癌伴盆腔淋巴结转移的作用。材料与方法:这是一项回顾性研究,研究对象为68例宫颈癌患者,他们在子宫切除术中发现了盆腔淋巴结转移,并于1983年至1996年在仁济大学首尔白克医院接受了盆腔照射。使用4 MeV直线加速器向骨盆进行外部束放射治疗,并通过阴道卵圆形或圆柱体进行腔内照射。通过Kaplan-Meier方法评估五年生存期和无病生存期,并通过对数秩检验和Cox比例风险回归模型分析与生存相关的预后因素。结果:中位随访时间为52个月。五年总生存率和无病生存率分别为81.8%和81.7%。子宫内膜浸润患者的5年DFS为57.1%,而没有子宫内膜浸润的患者为87.5%(p = 0.0074)。多变量分析显示子宫内膜浸润是5年DFS的唯一统计学意义的预后因素。在全部15例(22%)复发中,盆腔复发4例,远处转移发生13例。结论:我们已经能够证实先前的结果,表明骨盆照射后局部复发明显减少。鉴于本研究中发现的远处转移比例很高,看来有必要对具有盆腔淋巴结转移特别是子宫内膜浸润的早期宫颈癌患者进行积极的辅助系统治疗和放疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号